PP 2.14 – 00162 Elucidating the effects of combination therapy with Venetoclax and IAP inhibitor AZD5582 in SIV-infected, ART-suppressed macaques
B. Ukhueduan,
L. Lopez Lopez,
K. Bricker,
N. Schoof,
S. Vidisha,
D. Amir,
M. Mavigner,
A. Schauer,
M.L. Cottrell,
A. Chahroudi
Affiliations
B. Ukhueduan
Department of Pediatrics, Emory University, Atlanta, Georgia, USA
L. Lopez Lopez
Department of Pediatrics, Emory University, Atlanta, Georgia, USA
K. Bricker
Department of Pediatrics, Emory University, Atlanta, Georgia, USA
N. Schoof
Department of Pediatrics, Emory University, Atlanta, Georgia, USA
S. Vidisha
Department of Pediatrics, Emory University, Atlanta, Georgia, USA
D. Amir
Department of Pediatrics, Emory University, Atlanta, Georgia, USA
M. Mavigner
Department of Pediatrics, Emory University, Atlanta, Georgia, USA
A. Schauer
Emory National Primate Research Center, Emory University, Atlanta, Georgia, USA
M.L. Cottrell
Center for Childhood Infection and Vaccine of Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia, USA; Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
A. Chahroudi
Center for Childhood Infection and Vaccine of Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia, USA
